SCHEMBL25518013

SCHEMBL25518013

Cc1ccccc1-c1oc2cccnc2[n+]1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 8/20 0.39
▸ RAB9A P51151 8/20 0.39
▸ SMN1; SMN2 Q16637 6/20 0.39
▸ CASP3 P42574 2/20 0.39
▸ SENP8 Q96LD8 2/20 0.39
▸ SENP7 Q9BQF6 2/20 0.39
▸ SENP6 Q9GZR1 2/20 0.39
▸ GAA P10253 3/20 0.35
▸ L3MBTL1 Q9Y468 3/20 0.35
▸ MITF O75030 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ KDM4E B2RXH2 4/20 0.35
▸ MAPT P10636 4/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ TP53 P04637 3/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ TSHR P16473 2/20 0.35
▸ HPGD P15428 3/20 0.34
▸ ATM Q13315 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25518039 0.80 NPC1 (0.40) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL25517991 0.79 NPC1 (0.40) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL25518011 0.76 NPC1 (0.39) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL15315030 0.68 HTT (0.32) KDM4EALDH1A1HSD17B10
SCHEMBL25518014 0.67 DCTPP1 (0.36) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL26827035 0.66 ATM (0.36) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL25911861 0.64 NOS3 (0.35) NPC1RAB9ASMN1; SMN2L3MBTL1KDM4E
SCHEMBL9963986 0.63 NOS3 (0.46) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL4160810 0.63 CYP2A6 (0.52) NPC1RAB9ASMN1; SMN2CASP3SENP8
SCHEMBL2556578 0.62 CYP1A2 (0.58) NPC1RAB9ASMN1; SMN2CASP3SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230309394-A1 ORGANIC ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-09-28 — — US disclosed
US-20230250118-A1 ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-08-10 — — US disclosed
US-20230144101-A1 LIGHT-EMITTING MATERIAL WITH A POLYCYCLIC LIGAND Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-05-11 — — US disclosed
EP-4174078-A1 ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-05-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230250118-A1 ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF CRY1, LEF1, PIEZO1 NPC1 4075/4885RAB9A 834/4885SMN1; SMN2 3203/4885
US-20230144101-A1 LIGHT-EMITTING MATERIAL WITH A POLYCYCLIC LIGAND TRPC4, CRY1, TRPC1 NPC1 3269/4885RAB9A 899/4885SMN1; SMN2 3618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback